Valvular & structural heart diseaseResearch article
Tricuspid Regurgitation
- Narrative review
Study context
- Population
- Patients with tricuspid regurgitation (TR)
Main finding
As reported in the abstract
Key points and methods for TR detection, quantitation, categorization, risk-scoring, intervention-monitoring, outcomes evaluation and clinical trial development and conduct
- TR is highly prevalent and heterogeneous, independently associated with excess mortality and high morbidity in all clinical contexts
- TR is profoundly undertreated by surgery and often discovered late in patients presenting with right-sided HF
- Numerous structural tricuspid interventional devices in development; challenging given the valve's unique anatomic and physiological characteristics, warranting well-designed clinical trials
Original publication
Tricuspid Regurgitation. JACC Cardiovasc Imaging. Published 20 September 2023. doi:10.1016/j.jcmg.2023.08.013
Summarised from the published abstract; every number is checked against it